Global Markets for Antifungal Agents - Technologies and Industry Analysis, Share, Size, Trends, Opportunities and Forecast, 2012 - 2020 by RahulBose18


									Global Markets for Antifungal Agents - Technologies and Industry Analysis, Share, Size,
Trends, Opportunities and Forecast, 2012 – 2020

Get the full access of the report at

The global antifungal agents market is already established. However, it is necessary to
understand and examine the antifungal market growth of developing products in terms of
effectiveness. Fungi have proved drug-resistant to some compounds and therapies in the recent
past. Fungal infections in humans occur due to unhygienic, moist and unclean environment.
Even, dermal infections are mostly tinea infections, which affect hair, scalp, nails, and the skin.
Besides this, cases of candidiasis, mucormycosis, and meningitis are found in people, which may
not be lethal but cause discomfort and uneasiness for the patients and the surroundings. Thus,
where cases of fungal infestations are on a steep rise in humans, plants, animals, and the
environment with some having lethal consequences, identifying new antifungal research,
development and new drug applications is critical to grow in the marketplace.

Global anti-infective drugs market is expected to reach about 102 billion billion by the end of
2015. The antifungal agents market provides immense opportunities as number of antifungal
drug launches in recent years have been very less in comparison to other anti-infective
drugs. Antifungal therapies intend at eradicating fungi through several action mechanisms,
including destruction of cell walls, inhibition of cell division, or modification of fungal DNA and
cell functioning. The antifungal therapy agents market comprises several applications – powders,
drugs, ointments, and pastes. Increasing unhygienic conditions in developing countries and in
some developed countries worldwide, and rising cases of resistant fungal infections are major
growth factors for the global antifungal agents market. However, preferred use of traditional
medicines to control fungus by infected individuals and allergic reaction to certain antifungal
drugs may impede the growth of this market. Although these restraints are prevalent in the
market, the antifungal drugs market’s shift to over-the-counter status has already initiated the
growth for this market. Even, recent technological advancements are easing things up for
physicians in extracting and treating the infection effectively.

The global market for antifungal agents is segmented in terms of types, applications and
geography. The global antifungal agents market by type is classified into echinocandins, azoles,
ployenes, and other. On the basis of applications, this market is segmented into powders,
ointments, drugs and pastes. Markets by therapeutic indications are segmented as aspergillosis,
dermatophytosis, candidiasis and others. The global antifungal agents market segmentation by
geography includes North America, Asia Pacific, Europe, Latin America and RoW. Leading
market players are Pfizer, Glaxosmithkline, Bayer Healthcare, Kramer Laboratories, Novartis,
Enzon Pharmaceuticals, Abbott Laboratories, Sanofi-Aventis, Merck & Co., and Gilead.
Research development collaborations, mergers and acquisitions, and product launches are certain
market strategies that these companies have been adopting. For example, Pfizer received
approval by the European Commission to market Vfend for the treatment of life-threatening
fungal infections.

Market attractiveness analysis, compares various drug type, therapeutic indication and
applications within their respective markets along with factors responsible for the most attractive
market. Market attractiveness analysis for the most attractive geographical region worldwide is
also considered and has detailed study of factors responsible for rapid growth in the regions.
Various economic factors which are significant in determining market trend, buying decisions
and market attractiveness had been analyzed for market estimation and forecasting. Detailed
elaboration of drivers, restraints and opportunities in the report will enable in strategic decision
making with perceptive to identify potential market. In addition to this, the study also discusses
various environmental and regulatory factors critical for the market growth. Thus, estimation of
market numbers, with due consideration to all these factors has helped in enhancing the scope of
the report. This analysis will support stakeholders such as manufacturers and distributers in
identifying and capturing markets with high potential. Historical data is provided for 2011, 2012
whereas forecast is available through 2020 in terms of revenue (million) for each and every

The Global Antifungal Agents Market Segmentation is as follows:

By Drug Type

      Echinocandins
      Azoles
      Ployenes
      Allylamines
      Others

By Therapeutic Indication

      Aspergillosis,
      Dermatophytosis
      Candidiasis
      Others
By Application

      Powders
      Ointments
      Drugs
      Pastes

By Geography

      North America
      Asia Pacific
      Europe Middle East and Africa (EMEA)
      Latin America

About Us:

       Allied Market Research (AMR) is a full-service market research and business consulting
       wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides
       global enterprises as well as medium and small businesses with unmatched quality of
       “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted
       view to provide business insights and consulting to assist its clients to make strategic
       business decisions and achieve sustainable growth in their respective market domain.


       Sona Padman
       5320 SW Macadam Avenue,
       Suite 100, Portland, OR 97239
       United States
       Direct: +1 (617) 674-4143
       Toll Free: +1 (855) 711-1555 (U.S. & Canada)
       Fax: +1 (855) 550-5975

To top